Stock Scorer

Universal Health Services Inc (UHS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. Every figure as a table ›

Revenue Quarterly

0 2B 4B 6B Q3 '21: 3.2B Q4 '21: 3.3B Q1 '22: 3.3B Q2 '22: 3.3B Q3 '22: 3.3B Q4 '22: 3.4B Q1 '23: 3.5B Q2 '23: 3.5B Q3 '23: 3.6B Q4 '23: 3.7B Q1 '24: 3.8B Q2 '24: 3.9B Q3 '24: 4B Q4 '24: 4.1B Q1 '25: 4.1B Q2 '25: 4.3B Q3 '25: 4.5B Q4 '25: 4.5B Q1 '26: 4.5B Q2 '26: 4.6B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

0 200M 400M 600M Q3 '21: 314.8M Q4 '21: 313.6M Q1 '22: 232.9M Q2 '22: 233.4M Q3 '22: 275.9M Q4 '22: 261.4M Q1 '23: 278.7M Q2 '23: 280.1M Q3 '23: 285.4M Q4 '23: 331.2M Q1 '24: 388.8M Q2 '24: 436.4M Q3 '24: 384.2M Q4 '24: 472.5M Q1 '25: 454.8M Q2 '25: 500.3M Q3 '25: 521.7M Q4 '25: 517.2M Q1 '26: 502.9M Q2 '26: 516.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

0 200M 400M 600M Q3 '21: 218.4M Q4 '21: 239.1M Q1 '22: 153.9M Q2 '22: 164.1M Q3 '22: 182.8M Q4 '22: 174.8M Q1 '23: 163.1M Q2 '23: 171.3M Q3 '23: 167M Q4 '23: 216.4M Q1 '24: 261.8M Q2 '24: 289.2M Q3 '24: 258.7M Q4 '24: 332.4M Q1 '25: 316.7M Q2 '25: 353.2M Q3 '25: 373M Q4 '25: 445.9M Q1 '26: 348.7M Q2 '26: 358.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

0 250M 500M 750M Q3 '21: 442.2M Q4 '21: 322M Q1 '22: 445.4M Q2 '22: 32.6M Q3 '22: 220.7M Q4 '22: 297.3M Q1 '23: 290.8M Q2 '23: 362.9M Q3 '23: 161.7M Q4 '23: 452.4M Q1 '24: 396.4M Q2 '24: 679.3M Q3 '24: 333M Q4 '24: 658.4M Q1 '25: 360M Q2 '25: 549M Q3 '25: 380.7M Q4 '25: 574.7M Q1 '26: 401.6M Q2 '26: 443.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-300M -150M 0 150M 300M 450M Q3 '21: 258.4M Q4 '21: 132.4M Q1 '22: 245.4M Q2 '22: -175.3M Q3 '22: 59.1M Q4 '22: 132.9M Q1 '23: 122M Q2 '23: 195M Q3 '23: -38.3M Q4 '23: 246M Q1 '24: 187.9M Q2 '24: 437.9M Q3 '24: 85M Q4 '24: 412.5M Q1 '25: 121M Q2 '25: 283M Q3 '25: 151.8M Q4 '25: 293.5M Q1 '26: 184.5M Q2 '26: 215.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 30M 60M 90M Q1 '20: 86.5M Q2 '20: 85.1M Q3 '20: 85.2M Q1 '21: 85.8M Q2 '21: 85.6M Q3 '21: 83.7M Q1 '22: 76M Q2 '22: 74.4M Q3 '22: 73.1M Q1 '23: 71.5M Q2 '23: 70.8M Q3 '23: 69.6M Q1 '24: 68.5M Q2 '24: 67.9M Q3 '24: 68.1M Q1 '25: 66M Q2 '25: 65M Q3 '25: 63.7M Q1 '26: 61.7M Q2 '26: 59.9M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 9.00 18.00 27.00 Q3 '21: 12.42 Q4 '21: 11.81 Q1 '22: 11.40 Q2 '22: 9.81 Q3 '22: 9.71 Q4 '22: 9.15 Q1 '23: 9.41 Q2 '23: 9.63 Q3 '23: 9.53 Q4 '23: 10.24 Q1 '24: 11.78 Q2 '24: 13.62 Q3 '24: 15.02 Q4 '24: 16.82 Q1 '25: 17.80 Q2 '25: 18.97 Q3 '25: 21.03 Q4 '25: 23.12 Q1 '26: 23.97 Q2 '26: 24.52 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

Not drawn for UHS: Gross Profit, Cost of Revenue. Nothing in this filer's XBRL supports them for the periods asked for. That is a gap in the filing, not a zero, and drawing a flat line would be an invention.